En Es

Industry News

Utilization of X-Ray Mammography Systems Expected to Increase

By Medimaging International staff writers
10 Oct 2018

Image: The Mammomat Revelation mammography system (Photo courtesy of Siemens Healthineers).Over the last 20 years, hospitals and imaging centers in the developed economies have adopted X-ray mammography systems for the screening and diagnosis of breast cancer. This has resulted in a significant reduction in mortality and encouraged emerging countries to make investments in population-base, organized screening. These significant investments in mammography technology have paved the way for radiation safety, patient comfort and 3D imaging that enables precise tumor detection.

These are the latest findings of Frost & Sullivan, (Santa Clara, CA, USA), a global management consulting company.

Traditionally, highly populated countries have been slow to adopt non-conventional business models, although government initiatives for promoting early tumor detection are anticipated to drive the use of X-ray mammography imaging solutions in these countries. China and Eastern European nations such as Hungary and Poland are likely to be growth hubs for mammography solutions with the governments in these countries rolling out organized, population-based screening. India and other countries in Eastern Europe, such as Romania, are still in the development phase. Vendors in these markets are strategically employing leasing, managed equipment services, and various rental and pay-per-use models to drive procedural volumes. Moreover, new business models that focus on workflow efficiency will be the most feasible on account of the high budget deficits in these markets. At the same time, the evolution of payment models toward outcome-based reimbursement underlines the need for precision diagnosis.

According to Frost & Sullivan, vendors looking to expand their footprint and monetize growth opportunities in the X-ray mammography imaging solutions market need to:
• Offer value-adds through additional software services and improve the value proposition for clinical and financial stakeholders;
• Realign care models to focus on painless patient comfort systems that standardize compression pressure with minimum radiation dose;
• Deliver a fully integrated solution that provides access to medical imaging data as telemammography consultation gains currency;
• Introduce technologies focusing on microcalcifications and breast density assessment; and
• Collaborate with radiographers, medical physicists, and radiologists.
Technology developments in dose reduction, optimization, specificity, and sensitivity for early tumor detection will ensure that mammography remains the preferred imaging tool for breast cancer detection.

"Although analog and computed radiography (CR) mammography will continue to generate revenues from developing economies over the next three to five years, their increasing obsolescence will present considerable opportunities for 2D digital radiography (DR) systems," said Poornima Srinivasan, an industry analyst at Frost & Sullivan. "Studies show that digital breast tomosynthesis (DBT) is a game-changing technology for screening programs due to its ability to detect tumors in women with dense breast tissue. Similarly, 2D DR mammography with 3D DBT enhancement and synthesized 2D imaging also offer high price-performance value."

"To further improve product uptake, vendors are positioning 3D with multi-modality views, setting up workstations with 2D and 3D comparisons, and creating advanced detectors and algorithms to detect cancer at an early stage," added Srinivasan. "Significantly, they are also launching technologies such as contrast-enhanced spectral mammography, which provides low-energy 2D mammographic imaging on par with magnetic resonance imaging (MRI)."

Related Links:
Frost & Sullivan

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

23 Nov 2018
AI Predicts Alzheimer’s Disease Years before Diagnosis
A new study on the application of deep learning (DL) to detect changes in brain metabolism predictive of Alzheimer’s disease (AD) has found that artificial intelligence (AI) improves the ability of brain imaging to predict AD.
Read More
23 Nov 2018
UK to Set Up New GBP 10 Million Centre for Medical Imaging and AI
The UK’s London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare will train sophisticated artificial intelligence (AI) algorithms from NHS medical images and patient data, to create tools that will help clinicians speed up and improve diagnosis and care across a number of patient pathways, including dementia, heart failure and cancer.
Read More
23 Nov 2018
New AI Algorithm Enhances Polyp Detection in Colonoscopy Procedures
Researchers at Shanghai Wision AI Co., Ltd., a developer of computer-aided diagnostic algorithms and systems to improve the accuracy and effectiveness of diagnostic imaging, have announced results of a study validating a novel machine-learning algorithm that improves detection of adenomatous polyps during colonoscopy. The AI algorithm is built on the same network architecture that is used to develop self-driving cars and is designed to enable “self-driving” in colonoscopy procedures.
Read More
20 Nov 2018
Study Finds AI Falls Short When Analyzing Medical Data
A study conducted at the Icahn School of Medicine at Mount Sinai has found that artificial intelligence (AI) tools trained to detect pneumonia on chest X-rays suffered significant decreases in performance when tested on data from outside health systems. These findings suggest that unless AI in the medical space is carefully tested for performance across a wide range of populations, the deep learning models may not perform as accurately as expected.
Read More
20 Nov 2018
New AI Software for Brain Bleed Diagnosis Receives FDA Clearance
The US Food and Drug Administration (FDA) has given 510(k) clearance to the Accipio Ix intracranial hemorrhage (ICH) detection software developed by MaxQ AI, a clinical diagnostics intelligence platform company.
Read More
20 Nov 2018
Global Refurbished Medical Devices Market to Increase by 10% by 2023
The global refurbished medical devices market is expected to grow at a CAGR of over 10% during the forecast period 2019-2023, driven by the organized healthcare ecosystem in the developed economies. Moreover, privatization in the healthcare sector is increasing rapidly due to the inability of governments to invest efficiently in the sector, coupled with high demand for innovation and technology for superior healthcare services.
Read More
12 Nov 2018
ACR Data Science Institute Releases AI Use Cases to Accelerate AI Adoption
The American College of Radiology Data Science Institute has released a first-of-its-kind series of standardized artificial intelligence (AI) use cases that will accelerate medical imaging AI adoption. This continually updated, freely available use case series is the product of a previously missing and collaborative framework that enables efficient creation, implementation and ongoing improvement of radiological AI tools.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
12 Nov 2018
OpenSight Augmented Reality System for Microsoft HoloLens Cleared by FDA
The FDA has granted 510(k) clearance to the OpenSight Augmented Reality System, making it the first AR medical solution for Microsoft HoloLens to be cleared for use in pre-operative surgical planning. Developed by Novarad, a provider of specialized enterprise imaging and workflow solutions, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions